Melvin R. Hayden

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

Melvin R. Hayden, Suresh C. Tyagi · Nutrition & Metabolism · 2004 · 397 citations · Full text

Life Sciences, Biochemistry, Endocrinology +13

Sodium glucose transporter 2 (SGLT2) inhibition with empagliflozin improves cardiac diastolic function in a female rodent model of diabetes

Javad Habibi, Annayya R. Aroor, James R. Sowers et al. · Cardiovascular Diabetology · 2017 · 274 citations · Full text

Medicine, Cardiology, Pharmacology +17

Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: The pleiotropic effects of folate supplementation

Melvin R. Hayden, Suresh C. Tyagi · Nutrition Journal · 2004 · 184 citations · Full text

Medicine, Endocrinology, Metabolic Regulation +16

Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury

Annayya R. Aroor, Nitin A. Das, Andrea J. Carpenter et al. · Cardiovascular Diabetology · 2018 · 178 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic Stiffness in Females

Guanghong Jia, Javad Habibi, Annayya R. Aroor et al. · Circulation Research · 2016 · 174 citations

Life Sciences, Nutritional Sciences, Physiology +17